No correlation was found between the expression of VEGF-D or VEGFR-3 and the clinicopathological characteristics of the tumor (Supplementary Table S1); therefore, the next steps of the study were conducted considering exclusively serum VEGF-D. Here, FLT4 is linked to neoplasm.